The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The mineral and bone disorder treatment market has experienced robust growth, surging from $3.06 billion in 2023 to an anticipated $3.3 billion in 2024, boasting a significant Compound Annual Growth Rate (CAGR) of 8.0%. This growth is attributed to various factors such as chronic kidney disease, an aging population, increased awareness of mineral and bone disorders, the availability of advanced treatments, and rising disposable income levels.

A Glimpse into the Future
The positive trajectory is expected to continue, with the market poised to reach $4.34 billion in 2028 at a commendable CAGR of 7.1%. Contributing factors include a rising demand for quality of life treatments, a surge in demand for personalized medicine, increased government spending on healthcare, and a growing awareness of the significance of early diagnosis. Noteworthy trends in the forecast period encompass advancements in medical research, pharmaceutical developments, digital health, biologic therapies, and the integration of telehealth and remote monitoring.

Embracing the Aging Population
The surge in the elderly population is expected to be a key driver for the growth of the mineral and bone disorder treatment market. Defined as individuals aged 65 or older, the elderly demographic experiences muscle and bone mass loss, leading to weakness and reduced strength. Mineral and bone treatments play a pivotal role in preventing age-related changes, strengthening bones, and slowing down the pace of bone loss. According to the World Health Organization (WHO), the number of people aged 60 or older is projected to increase from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. Additionally, the number of individuals aged 80 or older is expected to triple from 143 million in 2020 to 426 million in 2050, underscoring the vital role of treatments in this demographic.

Leading Players in the Market
Major players in the mineral and bone disorder treatment market include Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, and others. These key players contribute significantly to the development and provision of advanced solutions for mineral and bone disorder treatment.

View More On The Mineral And Bone Disorder Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

New Product Development Takes Center Stage
Major companies in the market are focusing on developing new products and obtaining approvals to fortify their market position. The increase in drug approvals is particularly notable, driven by the aging population and the growing prevalence of chronic kidney diseases. An example is TYMLOS (abaloparatide), a synthetic form of the human parathyroid hormone, developed by Radius Health Inc. and approved in December 2022. This drug aims to increase bone density in men with osteoporosis at high risk of fracture, serving as an anabolic agent by selectively activating the parathyroid hormone 1 receptor (PTH1R) expressed in osteoblasts and osteocytes.

Strategic Acquisitions for International Expansion
In a strategic move, Abiogen Pharma Spa, an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for $8.77 million in May 2023. This acquisition aligns with Abiogen’s growth strategy, providing a platform for international expansion and emphasizing their commitment to improving osteoarticular and bone metabolism diseases. EffRx Pharmaceuticals SA, based in Switzerland, is actively involved in treating various disorders, including mineral and bone disorders.

Market Segmentation
The mineral and bone disorder treatment market is segmented into:

1. Treatment: Diet, Nutrition, Medication, Supplements, Dialysis
2. Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3. End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Regional Leadership
In 2023, North America emerged as the largest region in the mineral and bone disorder treatment market, showcasing the region’s significant contributions to advancing treatments and research.

Request A Sample Of The Global Mineral And Bone Disorder Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12956&type=smp

The Mineral And Bone Disorder Treatment Global Market Report 2023  provides a comprehensive overview on the mineral and bone disorder treatment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Blood Culture Tests Global Market Report 2023
Blood Transfusion Diagnostics Global Market Report 2023
Blood Cancer Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model